Quick Takeaways
- Kush Parmar has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $33,102,419.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Kush Parmar
- Location
- San Francisco, CA
- Summary
- The estimated net worth of Kush Parmar is at least $33,102,419 dollars as of 18 Nov 2025. Kush Parmar is the Director, 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $32.83M. Kush Parmar is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $241.6K. Kush Parmar is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
- Signature
- /s/ Kush Parmar
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kush Parmar and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Entrada Therapeutics, Inc. ($32,831,654).
- Past-year value change for that position: -$2,829,187.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Kush Parmar
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | Director, 10%+ Owner | $32,831,654 | -$2,829,187 | -7.9% | 14 Nov 2025 |
| QTTB | Homology Medicines, Inc. | Director | $241,560 | 15 Jun 2022 | ||
| RLYB | Rallybio Corp | Director | $29,205 | 15 May 2024 | ||
| AKUS | Akouos, Inc. | Director, 10%+ Owner | 30 Nov 2022 | |||
| VOR | Vor Biopharma Inc. | Director, 10%+ Owner | 14 Jun 2022 |
Insider Transactions Reported by Kush Parmar:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.